Back to search
FDAFDA · Food and drugs·Recall number D-1484-2020

Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50

Published August 12, 2020 · Recall initiated: July 7, 2020

Summary

FDA records drug Class I recall D-1484-2020, published August 12, 2020 and initiated July 7, 2020. Recalling firm: Mylan Institutional LLC; Status: Terminated; Reported quantity: 18,480 vials; Lot: Lot #: 7605112, Exp 10/2021. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email if DAPTOMYCIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAPTOMYCIN
Manufacturer
Mylan Institutional LLC
Distributor
USA Nationwide
Lot
Lot #: 7605112, Exp 10/2021
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50 recalled?

Yes. FDA published recall D-1484-2020 on August 12, 2020. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAPTOMYCIN.